Sumitomo Pharma Co., Ltd.: all 273 studies

Page 2 of 3. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.

• Major Depressive Disorder With Mixed Features - ExtensionCompletedNCT01423253Phase 3Results posted
• Major Depressive Disorder (MDD) With Mixed Features - Flexible DoseCompletedNCT01421134Phase 3Results posted
• Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal SprayCompletedNCT01401465Phase 3Results posted
• Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic RhinitisCompletedNCT01378429Phase 3Results posted
• A Phase 1 Scintigraphy Study to Assess Nasal Deposition of Ciclesonide. Using a Novel Nasal Metered Dose InhalerCompletedNCT01371786Phase 1Results posted
• Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or DivalproexCompletedNCT01358357Phase 3Results posted
• A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced MalignanciesCompletedNCT01325441Phase 1/2Results posted
• Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic RhinitisCompletedNCT01287364Phase 3Results posted
• Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I DepressionCompletedNCT01284517Phase 3Results posted
• Thymus Transplantation Safety-EfficacyCompletedNCT01220531Not applicableResults posted
• A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective DisorderCompletedNCT01143090Phase 3Results posted
• A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic AgentsCompletedNCT01143077Phase 3Results posted
• Safety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current AntiepilepticCompletedNCT01091662Phase 3Results posted
• A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and OlderCompletedNCT01067105Phase 3Results posted
• Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) AxisCompletedNCT01033825Phase 3Results posted
• Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and OlderCompletedNCT01010971Phase 3Results posted
• A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and OlderCompletedNCT00953147Phase 3Results posted
• Eslicarbazepine Acetate Monotherapy Long Term StudyCompletedNCT00910247Phase 3Results posted
• Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) SubjectsCompletedNCT00909779Phase 3Results posted
• Lurasidone - A 24-week Extension Study of Patients With Bipolar I DepressionCompletedNCT00868959Phase 3Results posted
• Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)CompletedNCT00868699Phase 3Results posted
• Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)CompletedNCT00868452Phase 3Results posted
• Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic DrugsCompletedNCT00866775Phase 3Results posted
• Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated InsomniaCompletedNCT00857220Phase 3Results posted
• Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated InsomniaCompletedNCT00856973Phase 3Results posted
• A Safety, Efficacy and Tolerability Study in Pediatric Subjects With AsthmaCompletedNCT00809757Phase 3Results posted
• Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.CompletedNCT00790192Phase 3Results posted
• Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic RhinitisCompletedNCT00790023Phase 3Results posted
• Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic SchizophreniaCompletedNCT00789698Phase 3Results posted
• Study of SM-13496 (Lurasidone HCl) in Patients With SchizophreniaCompletedNCT00711269Phase 3Results posted
• Phase3 Study of Amrubicin With Cisplatin Versus Etoposide-cisplatin for Extensive Disease Small Cell Lung CancerCompletedNCT00660504Phase 3Results posted
• Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable SchizophreniaCompletedNCT00641745Phase 3Results posted
• Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD SubjectsCompletedNCT00616655Phase 2Results posted
• Lurasidone HCl A Phase 3 Study of Patients With Acute SchizophreniaCompletedNCT00615433Phase 3Results posted
• A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric SubjectsCompletedNCT00583947Phase 2Results posted
• Phase I/II Thymus Transplantation With Immunosuppression #950CompletedNCT00579527Phase 1/2Results posted
• Thymus Transplantation Dose in DiGeorge #932CompletedNCT00576836Phase 2Results posted
• Thymus Transplantation in DiGeorge Syndrome #668CompletedNCT00576407Phase 2Results posted
• Efficacy Safety Study of Arformoterol QD Dosing Versus BID Dosing in COPDCompletedNCT00571428Phase 4Results posted
• Lurasidone HCl: A Phase 3 Study of Patients With Acute SchizophreniaCompletedNCT00549718Phase 3Results posted
• Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00424528Phase 4Results posted
• SMP-986 Phase 2 Proof of Concept in Patients With Overactive Bladder Syndrome (OABS)CompletedNCT00409539Phase 2Results posted
• A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic InsomniaCompletedNCT00386334Phase 4Results posted
• Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's DiseaseCompletedNCT00359944Phase 2Results posted
• Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT00250679Phase 3Results posted
• A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of SchizophreniaCompletedNCT00088634Phase 2Results posted
• A Study to Test the Safety and Tolerability of a New Medication in the Treatment of SchizophreniaCompletedNCT00088621Phase 2Results posted
• A Comparison of Study Drug With Placebo and Haloperidol in Patients With SchizophreniaCompletedNCT00044044Phase 2Results posted
• Safety and Tolerability Study of Drug to Treat SchizophreniaCompletedNCT00044005Phase 2Results posted
• TP-3654 Food Effect StudyCompletedNCT07492355Phase 1
• How [14C]-DSP-5336 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Patients With Advanced Blood CancersCompletedNCT07444268Phase 1
• A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP)Active, not recruitingNCT06517940
• First-in-human Study to Assess the Safety, Tolerability and Immunogenicity of the Adjuvanted Universal Influenza Vaccine fH1/DSP-0546LPCompletedNCT06460064Phase 1
• Assessment of Relative Bioavailability and Effect of Food on Capsule and Tablet Formulations of TP-3654CompletedNCT06389955Phase 1
• Thorough QT Study to Evaluate the Effect of Rodatristat Ethyl, Rodatristat and Its Major Metabolites on the HeartCompletedNCT05933447Phase 1
• MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination TherapyActive, not recruitingNCT05739136
• A Single and Multiple Dose of Rodatristat Ethyl in Healthy Adult Subjects to Evaluate the Effect of Food and SafetyCompletedNCT05684640Phase 1
• A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYXCompletedNCT05467176
• A Pharmacodynamics and Safety Study of DSP-9632P in Patients With Levodopa-Induced Dyskinesia in Parkinson's DiseaseCompletedNCT05435729Phase 1
• A Clinical Trial to Evaluate the Long-term Safety and Tolerability of SEP-363856 in Patients With Schizophrenia in JapanTerminatedNCT05359081Phase 3
• The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From OlanzapineTerminatedNCT05213143Phase 4
• Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB)CompletedNCT05067478
• Multiple-Ascending Dose in Japanese Patients Bridging StudyCompletedNCT05065359Phase 1
• Study of DSP-0390 in Patients With Recurrent High-Grade GliomaActive, not recruitingNCT05023551Early Phase 1
• The Safety and Efficacy of Lurasidone With Different Initiation Dose in Chinese Acute Phase Patients With SchizophreniaCompletedNCT05011669Phase 4
• Pharmacokinetics and Excretion of Oral [14C]-Rodatristat EthylCompletedNCT05006118Phase 1
• Study of Relugolix Alone and Relugolix Combined With Hormonal Add-Back Therapy in Healthy Premenopausal Female ParticipantsCompletedNCT04978688Phase 1
• A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label Extension PhaseTerminatedNCT04825860Phase 2/3
• A Study of the Effects of Erythromycin on the Pharmacokinetics of Relugolix, Estradiol, and Norethindrone in Healthy Postmenopausal Women and on the Pharmacokinetics of Relugolix in Healthy Adult MenCompletedNCT04714554Phase 1
• Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate CancerCompletedNCT04666129Phase 1
• The Safety and Effectiveness of Latuda® Post-marketing Surveillance in the Treatment of Chinese Schizophrenia PatientsCompletedNCT04432688
• A Study of Lurasidone Compared With Placebo for the Treatment of Bipolar I DepressionTerminatedNCT04383691Phase 3
• Phase 1 Study of Oral TP-1454CompletedNCT04328740Phase 1
• Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Japanese Male and Female Subjects With SchizophreniaCompletedNCT04325737Phase 1
• Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored ProtocolsCompletedNCT04299880Phase 1
• A Study of RVT-1201 in Patients With Pulmonary Arterial Hypertension (ELEVATE 1)TerminatedNCT03924154Phase 2
• Effects on Social and Cognition Functions of Blonanserin in First Episode Schizophrenia PatientsTerminatedNCT03784222Phase 4
• Bone Mineral Density in Women With Uterine Fibroids or EndometriosisCompletedNCT03744507
• Study of TP-3654 in Patients With Advanced Solid TumorsCompletedNCT03715504Phase 1
• Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid TumorsTerminatedNCT03604783Phase 1
• A Study of DSP-2033 (Alvocidib) in Patients With Acute Myeloid LeukemiaCompletedNCT03563560Phase 1
• A Study to Evaluate the Mass Balance of 14C-Napabucasin in Healthy Adult Male SubjectsCompletedNCT03525405Phase 1
• First-in-human Study of Oral TP-0184 in Patients With Advanced Solid TumorsCompletedNCT03429218Phase 1
• A Study of DSP-0337 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic ProfileTerminatedNCT03416816Phase 1
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Drug Interaction Potential of Napabucasin in Healthy VolunteersCompletedNCT03411122Phase 1
• Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Japanese Male and Female Subjects With Schizophrenia in 2 Parts (Part 1 and 2).CompletedNCT03370640Phase 1
• Farber Disease Natural History StudyCompletedNCT03233841
• SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated PainCompletedNCT03204331Phase 3
• SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated PainCompletedNCT03204318Phase 3
• A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the DrugWithdrawnNCT03108729Phase 3
• Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver DysfunctionCompletedNCT02795637Phase 1
• A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade GliomasCompletedNCT02750891Phase 1/2
• First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid TumorsCompletedNCT02729298Phase 1
• A Study of BBI608 Administrated With FOLFIRI + Bevacizumab in Adult Patients With Metastatic Colorectal CancerCompletedNCT02641873Phase 1
• Efficacy and Safety of Arotinolol Hydrochloride on Morning Blood Pressure and Heart RateCompletedNCT02612298Phase 4
• Dasotraline Binge Eating Disorder StudyCompletedNCT02564588Phase 2/3
• An Exploratory Study of Genetic and Clinical Factors for Serious Skin Reactions Among Users of Eslicarbazepine AcetateTerminatedNCT02520557
• A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced MalignanciesCompletedNCT02498665Phase 1
• A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced CancerCompletedNCT02483247Phase 1
• A Study of BBI608 Administered in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced CancersCompletedNCT02467361Phase 1

← Sumitomo Pharma Co., Ltd. overview and focus areas